Kymera Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.5M | 177k | 25.46 |
| 2023-09-30 | $2.6M | 190k | 13.90 |
| 2023-06-30 | $5.2M | 177k | 29.63 |
| 2023-03-31 | $5.2M | 177k | 29.63 |
| 2022-12-31 | $4.5M | 180k | 24.96 |
| 2022-09-30 | $3.6M | 168k | 21.77 |
| 2022-06-30 | $3.8M | 194k | 19.69 |
| 2022-03-31 | $18M | 430k | 42.32 |
| 2021-12-31 | $17M | 266k | 63.49 |
| 2021-09-30 | $16M | 266k | 58.74 |
| 2021-06-30 | $14M | 282k | 48.50 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas